血友病B的基因治疗
Gene therapy for hemophilia B
摘要
血友病B是一种x染色体连锁隐性遗传病,因编码基因的改变而导致凝血因子Ⅸ(FⅨ)的缺乏。在男性中发病率约为1/25000,依据血浆FⅨ活性(FIX:c)分为重型(FIX:c〈1%)、中间型(FIX:C1%~5%)和轻型(FlX:C〉5%,≤40%)。目前该病主要治疗手段为替代治疗(输注血浆提取物或重组FIX制剂),
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2013年第9期809-811,共3页
Chinese Journal of Hematology
基金
国家重点基础研究发展计划(973)(2013CB966800)
国家自然科学基金(81070414)
参考文献35
-
1中华医学会血液学分会血栓与止血学组,中国血友病协作组.血友病诊断与治疗中国专家共识(2013年版).中华血液学杂志,2013,34:461-463.
-
2Kaufman RJ. Advances toward gene therapy for hemophilia at the millennium. Hum Gene Ther, 1999,10:2091-2107.
-
3Wang L, Louboutin JP, Bell P, et al. Muscle-directed gene therapy for hemophilia B with more efficient and less immunogenic AAV vectors. J Thromb Haemost, 2011,9: 2009-2019.
-
4Nathwani AC, Rosales C, Mclntosh J, et al. Long-term safety and efficacy following systemic administration of a self-comple- mentary AAV vector encoding human FIX pseudotyped with se- rotype 5 and 8 capsid proteins. Mol Ther, 2011,19:876-885.
-
5Allay JA, Sleep S, Long S, et al. Good manufacturing practice production of self-complementary serotype 8 adeno-associated viral vector for a hemophilia B clinical trial. Hum Gene Ther, 2011,22:595-604.
-
6Zhang J, Xu L, Haskins ME, et al. Neonatal gene transfer with a retroviral vector results in tolerance to human factor IX in mice and dogs. Blood, 2004,103:143-151.
-
7Kay MA, Rothenberg S, Landen CN, et al. In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-defi- cient dogs. Science, 1993,262:117-1 1 9.
-
8Ehrhardt A, Kay MA. A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation fac- tor IX at low doses in vivo. Blood, 2002,99:3923-3930.
-
9Vandendriessche T, Thorrez L, Acosta-Sanchez A, et al. Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy. J Thromb Haemost, 2007,5:16-24.
-
10Brown BD, Cantore A, Annoni A, et al. A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Blood, 2007,110:4144-4152.
二级参考文献11
-
1Viiala NO,Larsen SR,Rasko JE.Gene therapy for hemophilia:clinical trials and technical tribulations.Semin Thromb Hemost,2009,35:81-92.
-
2Jiang J,Yamato E,Miyazaki J.Intravenous delivery of naked plasmid DNA for in vivo cytokine expression.Biochem Biophys Res Commun,2001,289:1088-1092.
-
3Zhang G,Gao X,Song YK,et al.Hydroporation as the mechanism of hydrodynamic delivery.Gene Ther,2004,11:675-682.
-
4Kobayashi N,Nishikawa M,Hirata K,et al.Hydrodynamicsbased procedure involves transient hyperpermeability in the hepatic cellular membrane:implication of a nonspecific process in efficient intracellular gene delivery.J Gene Med,2004,6:584-592.
-
5Herweijer H,Zhang G,Subbotin VM,et al.Time course of gene expression after plasmid DNA gene transfer to the liver.J Gene Med,2001,3:280-291.
-
6Marx I,Lenting PJ,Adler T,et al.Correction of bleeding symptoms in von Willebrand factor-deficient mice by liver-expressed von Willebrand factor mutants.Arterioscler Thromb Vasc Biol,2008,28:419-424.
-
7Chen ZY,He CY,Meuse L,et al.Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo.Gene Ther,2004,11:856-864.
-
8Chen ZY,He CY,Ehrhardt A,et al.Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo.Mol Ther,2003,8:495-500.
-
9Bertoni C,Jarrahian S,Wheeler TM,et al.Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration.Proc Natl Acad Sci U S A,2006,103:419-424.
-
10Aneja MK,Imker R,Rudolph C.Phage phiC31 integrase-mediated genomic integration and long-term gene expression in the lung after nonviral gene delivery.J Gene Med,2007,9:967-975.
共引文献6
-
1马晴雯.φC31整合酶系统介导的位点特异性整合研究进展[J].遗传,2011,33(6):567-575. 被引量:5
-
2叶娟,许正新,陈金中,薛京伦.血友病非病毒载体基因治疗研究进展[J].医学综述,2012,18(1):33-35.
-
3吴希,陆晔玲,丁秋兰,戴菁,奚晓东,王鸿利,王学锋.凝血因子ⅧTrp1707Ser突变患者相关抑制物的结合作用机制研究[J].中华血液学杂志,2013,34(8):691-695. 被引量:2
-
4宣旻,付荣凤,薛峰,杨艳辉,张磊,杨仁池.单中心520例血友病患儿临床分析[J].中华血液学杂志,2013,34(11):913-917. 被引量:15
-
5郭志萍,陈剑芳,秦秀玉,张耀方,杨林花.重型血友病A患者凝血因子Ⅷ基因内含子22倒位检测[J].中华血液学杂志,2013,34(11):918-921. 被引量:8
-
6崔东艳,胡群.血友病基因治疗的研究进展[J].国际输血及血液学杂志,2018,41(1):85-89.
-
1张志清.血友病B基因治疗进展[J].青海师范大学学报(自然科学版),2002,18(2):59-61. 被引量:1
-
2施前,卢大儒,包云,陈煜华,邱信芳,薛京伦.肌细胞途径血友病B基因治疗高表达载体的构建及表达研究[J].高技术通讯,1998,8(3):38-41. 被引量:2
-
3王健民,侯军,KurachiK.原代小鼠骨骼肌细胞和C 2C 12细胞转人凝血因子IX基因后高效表达及分泌功能[J].第二军医大学学报,1999,20(9):593-597. 被引量:4
-
4黄淑帧,陈美珏,黄英,张克忠,李华,卢大儒,陆建英,陈云弟,邱信芳,薛京伦,曾溢滔.乳汁中分泌有活性的人凝血因子Ⅸ的转基因羊的研制[J].科学通报,1998,43(7):783-784. 被引量:24
-
5陈立,周虹,王健民,郝光荣,卢大儒,孙伟,周彩红,邱信芳,薛京伦.凝血因子Ⅸ基因剔除小鼠遗传稳定性及其临床表型研究[J].复旦学报(自然科学版),1999,38(4):435-438. 被引量:7
-
6谭骏,王燕,纪贤文,刘昕,朱锡华,薛京伦,邱信芳.人凝血因子Ⅸ基因(pKG_5-Ⅸ)直接注入小鼠骨骼肌中瞬间表达的研究[J].第三军医大学学报,1994,16(2):96-98.
-
7陈立,陈浩明,陆华中,吴小兵,卢大儒,邱信芳,薛京伦.腺相关病毒介导的小鼠IX因子在血友病B小鼠体内表达研究[J].中国科学(C辑),2003,33(2):175-181. 被引量:5
-
8张媛,杨林花,陆晔玲,丁秋兰,王学锋,刘秀娥,张丽.三个血友病B家系的基因诊断[J].中华血液学杂志,2008,29(3):179-182. 被引量:1
-
9胡群.儿童血友病的凝血因子替代治疗[J].中华实用儿科临床杂志,2013,28(15):1126-1127. 被引量:8
-
10叶晨波,高啸波,侍鼎,陈立,邱信芳,薛京伦.微小腺病毒介导的人凝血因子IX基因治疗血友病B小鼠研究[J].中国科学(C辑),2003,33(5):446-453. 被引量:2